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Hypoxia induces p53 accumulation in the S-phase and
accumulation of hypophosphorylated retinoblastoma
protein in all cell cycle phases of human melanoma
cells
T Danielsen, M Hvidsten, T Stokke, K Solberg and EK Rofstad
Departme of Biophysics, Insitute for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway
Summary Hypoxia has been shown to induce accumulation of p53 and of hypophosphorylated retinoblastoma protein (pRb) in tumour cells.
In this study, the cell cycle dependence of p53 accumulation and pRb hypophosphorylation in four human melanoma cell lines that are wild
type for p53 was investigated using two-parameter flow cytometry measurements of p53 or pRb protein content and DNA content. The
hypoxia-induced increase in p53 protein was higher in S-phase than in G1 and G2 phases in all cell lines. The accumulation of p53 in S-phase
during hypoxia was not related to hypoxia-induced apoptosis or substantial cell cycle specific cell inactivation during the first 24 h of
reoxygenat*on. pRb was hypophosphorylated in all cell cycle phases by hypoxia treatment. The results did not support a direct link between
p53 and pRb during hypoxia because p53 was induced in a cell cycle-specific manner, whereas no cell cycl-depernent differences in pRb
hypophosphorylation were detected. Only a fraction of the cell populations (0.60 ± 0.10) showed hypophosphorylated pRb. Thus, pRb is
probably not the only mediator of the hypoxia-induced cell cycle block seen in all cells and all cell cycle phases. Moreover, the cell cycle-
dependent induction of p53 by hypoxia suggests that the primary function of p53 accumulation during hypoxia is otherthan to arrest the cells.
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Hypoxia is a common feature of many human tumours (Moulder
and Rockwell. 1987: Vaupel et al. 1989). In vivo and in vitro
studies of human tumours and cell lines have shown that hypoxia
induces treatment resistance (Overgaard et al. 1986: Gatenby et al.
1988: Luk et al. 1990: Hockel et al. 1991: Sanna and Rofstad.
1994) and increases the genomic instability of tumour cells (Hill.
1990: Rofstad et al. 1996a). Cell proliferation is reduced or totally
inhibited by hypoxia (Pettersen et al. 1986; Moulder and
Rockwell. 1987) and cell viability is reduced (Hall et al. 1966:
Bedford and Mitchell. 1974). The reduced cell viability can be due
to energy depletion. however, other mechanisms might contribute
as well (Shrieve et al. 1983: Rotin et al. 1986: Graeber et al. 1996).
Hypoxic conditions modulate the expression of certain genes in
tumour cells (Brown and Giaccia. 1994). Among these. the pro-
ducts of the tumour-suppressor genes p53 and Rb (the retino-
blastoma gene) are important in the regulation of cell cycle
progression and cell viability.
The p53 protein is a 53-kDa nuclear phosphoprotein which
plays multiple roles in cells. Under normal conditions. little p53
protein is found in most cells. However. when cells are exposed to
stimuli that induce DNA damage. the p53 protein is stabilized and
accumulates in the nucleus. The p53 protein can. thereafter. act on
its transcriptional targets. including thep21 gene. the gadd45 gene
and the mdm-2 gene. and arrest the cells in theG, phase ofthe cell
cycle (Ko and Prives. 1996). It has been suggested that this G,
arrest allows the cells to repair DNA lesions and. thereby. maintain
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genomic integrity (Lane. 1992). If the repair fails. the accumula-
tion of p53 induced by DNA damage may trigger apoptosis.
Hypoxia has been shown to induce accumulation ofp53 protein in
the nucleus of most cell lines that are wild type forp53. but not in
cell lines that possess mutantp53 (Graeberet al. 1994: Amellem et
al. 1997). Cells are arrested in the cell cycle by hypoxia treatment
(Graeber et al. 1994: Amellem and Pettersen. 1991: Ludlow et al.
1993). However. this arrest seems to be independent of the p53
status (Graeber et al. 1994). and might. therefore. not be caused by
the p53 accumulation. Hypoxia treatment can induce apoptosis in
some cell lines (Muschel et al. 1995: Yao et al. 1995: Graeber et al.
1996: Shimizu et al. 1996: Amellem et al. 1997). The role of p53
in hypoxia-induced apoptosis is not completely clarified
(Amellem et al. 1997).
The retinoblastoma protein. pRb. is a nuclear phosphoprotein
which regulates the cell cycle. pRb is expressed in all cell types
and exists in an active hypophosphorylated and an inactive hyper-
phosphorylated state (Weinberg. 1995). Under normal conditions.
pRb is hypophosphorylated and bound to the nucleus only in early
G, phase (Mittnacht and Weinberg. 1991: Templeton. 1992:
Stokke et al. 1993). It is proposed that pRb serves as a brake on the
progression ofcells fromGI to S-phase of the cell cycle when the
protein is in its active state. Hypoxia treatment has been shown to
induce reversible hypophosphorylation ofpRb in all phases of the
cell cycle (Ludlow et al. 1993: Amellem et al. 1996). This
hypoxia-induced hypophosphorylation is probably independent of
p53 status. Moreover. pRb hypophosphorylation does not seem to
cause the hypoxia-induced arrest inGI (Amellem et al. 1996).
Studies of the cell cycle dependence of hypoxia-induced p53
accumulation have not been reported. nor have measurements of
hypoxia-induced changes in p53 and pRb in the same cell line.
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However, knowledge from such studies might elucidate the roles
of pRb and p53 in the regulation of cell proliferation and cell
viability under hypoxic conditions. In the present work, hypoxia-
induced cell cycle-dependent changes in pRb and p53 were inves-
tigated in the human melanoma cell lines A-07, D-12, R-18 and
U-25 by two-parameter flow cytometry measurements. The cell
cycle variability of these gene products was, thereafter, related to
proliferation and viability data to reveal information about the
functions ofp53 and pRb during hypoxia.
MATERIALS AND METHODS
Cell lines
Four established human melanoma cell lines (A-07. D-12, R-18.
U-25) were used (Rofstad, 1994). Mutations inp53 were analysed
by CDGE (constant denaturant gel electrophoresis) with primers
covering exon 5-8 (B0rresen, 1996), as well as by complete
sequencing of the p53 cDNA using primers covering the open
reading frame (Smith-S0rensen et al, 1998). The analysis showed
that all fourcell lines express wild-typep53. Cell lines were main-
tained in monolayer culture in RPMI-1640 medium (25 mm
HEPES andL-glutamine) supplemented with 13% fetal calfserum,
250 mg 1-1 penicillin and 50 mg 1-1 streptomycin. Cultures were
incubated at 37°C in a humidified atmosphere of 5% carbon
dioxide in air and subcultured by trypsinization (0.05%
trypsin/0.02% EDTA solution).
Exposure to hypoxia
Cells from cultures in exponential growth were plated in glass
dishes, incubated at 37°C in a humidified atmosphere of 5%
carbon dioxide in air for 24 h, and then exposed to hypoxia for
16 h. The culture medium was removed and replaced by fresh
medium supplemented with 2.2 g 1-' sodium bicarbonate immedi-
ately before hypoxia treatment. The glass dishes were placed in
air-tight steel chambers during the hypoxia tratment. The steel
chambers were flushed with a humidified, highly purified gas
mixture consisting of 95% nitrogen and 5% carbon dioxide at a
flow rate of 51 min-'. Measurements showed that the concentra-
tion ofoxygen in the medium was < 10p.p.m. after 1 h offlushing.
The pH in the medium at the end of the exposure was within the
range of7.3-7.5.
Cell proliferaton and survival during hypoxia
Cell proliferation during hypoxia was determined by counting
aerobic control cells orhypoxia-treated cells in a haemocytometer
and measuring DNA histograms by flow cytometry as described
previously (Sanna and Rofstad, 1994). Cell survival was measured
by using a colony assay (Rofstad, 1992). Briefly, 1-ml aliquots of
cell suspension were seeded in 25-cm2 tissue culture flasks,
containing 10- lethally irradiated feeder cells in 4 ml of medium.
After 8-21 days ofincubation at 37°C in a humidified atmosphere
of 5% carbon dioxide in air, cells were fixed in ethanol, stained
with methylene blue, and colonies containing more than 50 cells
were counted.
Ap tosis measuremes
Apoptotic cells were detected by immunofluorescence using the
ApopTag (Oncor) in situ assay (Yao et al, 1995). Cells washed in
Ca'+- and Mg'+-free Hank's buffered salt solution (HBSS) were
resuspended in 4% neutral-buffered paraformaldehyde for 10 min
at room temperature. Aliquots of approximately 50gl of cell
suspension were dropped on microscope slides. Two drops of
equilibration bufferwere added before the slides were incubated at
room temperature in a humidified atmosphere for 5 mnn.
Approximately 50 jtl of a terminal deoxynucleotide transferase
and digoxigenin-ll-deoxyuridine triphosphate solution was
applied to the cell preparations to end-label DNA frgments. The
slides were continuously incubated at 37°C for 1 h and washed in
prewarmed stop/wash buffer at 37°C for 30 min. Approximately
50 .tL ofan antidigoxigenin-fluorescein solution was pipetted onto
the slides for detection ofthe end-labelled DNA fragments before
the slides were incubated at room temperature for 30 min. Finally,
the slides were mounted under a glass coverslip with a drop of
propidium iodide/Antifade staining buffer. The cell preparations
were washed three times in phosphate-buffered saline (PBS)
between each step in the procedure. The cells were visualized by
epifluorescence using standard fluorescein excitation andemission
filters. The fraction of cells in apoptosis was determined by
scoring 500 cells in each sample.
Energy charge measurements
The relative concentraions ofadenylate phosphates in control cells
and cells exposed to hypoxia were measured by high performance
liquid chromatography at 254 nm. The medium ofthe cell cultures
was replaced with acetonitrile and the lysed cells were scraped off
the glass dishes. The cell lysates were dried and low-strength buffer
(100 mm potassium dihydrogen phosphate. 1.5% acetonitrile.
0.08% C16HH6NBr. pH 5.0) was added before the samples were
centrifuged. The supernatant was used in the further analysis. The
elution conditions that provided the best resolution were 80% low-
strength buffer and 20% high-strength buffer (150 mm potassium
dihydrogen phosphate, 10% acetonitrile. 0.08% tetrabutylammuo-
nium bromide, pH 5.0) for 10 min. followed by a linear gradient to
100% high-strength buffer during the next 10 min. Elution with the
high-strength buffer was continued for anothr 10 min. The separa-
tion was carried out with a Supelcosil LC-18-T 5-pm cartridge
(Supelco, USA). The flow rate was 1.0 ml min-'. The adenylate
energy charge was calculated by the equation:
[ATP] + 1/2[ADP]
Adenylate energy charge =
[ATP] + [ADP] + [AMP]
Staining for p53 or bound pRb and DNA content
Hypoxia-trated cells were stained for protein and DNA content
immediately after exposure to hypoxia. All steps were perfonned at
0°C. Harvested cells (approximately 2-3 x 106 cells per sample)
were washed once in PBS and resuspended in 750 of 10 mm
phosphate buffer (pH 7.4) containing 0.1% Nonidet P-40, 10 mM
sodium chloride, 5 mm magnesium chloride and 0.1 mM phenyl
methyl sulphonyl fluoride (PMSF). After Omin. the extrcted
cells, which will be termed 'nuclei', were vortexed and 250 gl of
4% paraformaldehyde was added. The nuclei were fixed for I h.
washed once with staining buffer [150 mM sodium chloride, 0.1%
Triton X-100, 2 mm magnesium chloride and 10 mm Tris-HCl (pH
7.4)] and centifuged. Staining was accomplished by a three-layer
procedure. The nuclei were resuspended in 30 RI staining buffer
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containing 5% dry milk. After 10 min, the monoclonal antibody
(PAb 1801, p53 Ab-2. Oncogene Science; PMG3-245, pRb,
Pharm-ingen) diluted in staining buffer was added to afinal concen-
tration of2.0jg ml-' (p53) or 10.0jg ml-' (pRb) in a total volume
of 60 1. The control samples received no primary antibody. After
incubation with the first layer for 1 h, the nuclei were washed once
with staining buffer and resuspended in 60 p1 secondary antibody
(biotinylated anti-mouse Ig from sheep, Amersham Life Science)
diluted 1:50 in staining buffer. The nuclei were incubated for 30
min, washed with staining buffer and resuspended in 60jl strepta-
vidin-ITC (FITC. fluorescein isothiocyanate) (Amersham Life
Science) diluted 1:50 in staining buffer. After incubation for 30
minu the nuclei were washed once with staining buffer and resus-
pended in 500g1 of staining buffer containing 2 jg ml-' Hoechst
33258. The samples were filtered through a 30-jm nylon mesh and
analysed in a flow cytometer.
Staining for BrdUrd and DNA content
To investigate the progression ofcells in the different phases ofthe
cell cycle afterhypoxia treatment, cells were incubated with 50 jg
ml' BrdUrd (5-bromo-2'-deoxyuridine) for 30 min immediately
before hypoxia treatment. The culture medium containing BrdUrd
was removed, the cells were washed severat times with PBS and
fresh medium supplemented with sodium bicarbonate was added
before hypoxia treatment. The cells were incubated at 37°C in a
humidified atmosphere of 5% carbon dioxide in air for various
times afterreoxygenation. Cells were harvested and fixed in 100%
methanol and stored at -20°C. Immunostaining for BrdUrd was
performed according to the protocol of Gerlyng et al (1992).
Briefly, the cells were digested in a suspension of 0.2% pepsin in
2 M hydrochloric acid and stained for BrdUrd by a three-layer
procedure. The anti-BrdUrd antibody (Becton Dickinson). the
secondary antibody (biotinylated anti-mouse Ig from sheep.
Amersham Life Science) and streptavidin-FITC (Amersham Life
Science) were diluted in PBS containing 0.5% Tween 20 and 0.5%
bovine serum albumin. PBS was employed for washing between
incubations. After incubation with streptavidin-FITC, the pellets
were washed once with PBS and resuspended in 500 jl of PBS
with 2.5 jg ml-' propidium iodide (Calbiochem) and 100 jg ml-
RNAase A (Pharmacia). The samples were filtered through a
30-jm nylon mesh and analysed in a flow cytometer.
Flow cytomew
The stained cells or nuclei were analysed in a FACStarP'Ls flow
cytometer (Becton Dickinson) equipped with two argon lasers
(SpectraPhysics) that were tuned to 488 nm and UV respectively.
FITC fluorescence, forward light scatter and side scatter pulse
amplitudes, as well as propidium iodide fluorescence pulse height.
pulse width and pulse area were measured upon excitation by the
488-nm laser. Hoechst 33258 fluorescence pulse height pulse
width and pulse area were measured upon excitation by the UV
laser. Hoechst 33258 fluorescence pulse area or propidium iodide
fluorescence pulse area were used as a measure of DNA content.
The nuclei were gated for doublet discrimination in a diagram of
integrated Hoechst 33258 fluorescence against Hoechst 33258
pulse width. The green fluorescence intensities were calibrated
with fluorescent beads in each experiment such that the FITC
fluorescence intensities measured in different expeiments could
be compared.
Data t nt and analysis
The median FITC fluorescence intensity (FLI-H) of the anti-p53-
stained sample subtracted by the median fluorescence intensity of
the corresponding control sample (which had received no primary
antibody) was used as a measure ofrelative level ofp53 protein in
the nuclei. Measurements of relative levels ofp53 protein in each
phase of the cell cycle were obtained by generating FLI-H
histograms from three narrow gates in the DNA histograms. T-47D
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Figure 2 Flow cytometic analysi of D-12 nucli stained for p53 protein and DNA content The hitograms show DNA content (integrated Hoechst 33258
fluorescence; F32-A) and p53 protein content (FITC fluorescence; FL1-H). Histograms A-D represent aerobic cells, whereas histograms E-K represent cells
exposed to hypoxia for 16 h. The dual parameter histogam A and E represent control cels which received no primary antbody against p53. The dual
parameter hi s B and F show the distribuon of stained p53 prtein in the nuclei throughout the cel cycle. The DNA content of these nucei is also shown
in one-parameter F32-A histograms (C and G). The gates Rl, R2 and R3 in these histograns were applied to generate FL1-H histograms for cells in G1 phase,
S-phase and G2 phase of the cell cyCe respeely. p53 protein Ctent of different cell cycle phases is shown for hypoxia-treated cells in histograms I-K
Histograms for total p53 protein lvel are shown in D and H
cells, which are mutant for p53, were used as a positive control.
They showed a relative level of p53 protein that was about 20
times the value of the untreated melanoma cells, which are wild
type forp53.
T'he extraction procedure provides samples where only the
detergent-resistant bound pRb is present, i.e. hypophosphorylated
pRb (Mittnacht and Weinberg, 1991; Templeton, 1992; Stokke et
al, 1993). At normal conditions, pRb is only bound in the nucleus
in G . Two distinct peaks with G, DNA content were observed in
the FL1-H histograms (FITC fluorescence) of aerobic nuclei.
Previous studies have shown that the PMG3-245 anti-pRb mono-
clonal antibody has a high degree of non-specific binding (Stokke
et al, 1993; Jonassen et al, 1994). The nuclei with low FL1-H fluo-
rescence intensities were, therefore, assumed to have only non-
specific binding of the pRb antibody, and were termed pRb-
nuclei. High FL1-H fluorescence intensities were assumed to
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Fgure 3 Calculated values of relative levels of p53 protein in the nucei of
aerobic cells (0) and hypoxic cells (C) in each phase of the cell cycle. Five
independent expenrmets with aerobic cells and cells treated with hypoxaa for
16 h were carried out for the four cell lines (A) A-07, (B) D-12, (C) R-18 and
(D) U-25
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Fhgure 4 Westem blot showing texpressionof p53 in A-07, D-12, R-18
and U-25 cells from aerobic control cels (C) and hypoxitreated cels (H).
Proteins from 5 x 105 cells were baded in each lane. The band below p53
was due to non-specific bincing, as shown in blots stained without the p53
antibody
represent nuclei with bound hypophosphorylated pRb. which were
called pRb+ nuclei. The fraction of pRb+ nuclei was obtained by
measuring the relative number ofnuclei with high FL1-H. In addi-
tion to omission ofthe primary antibody. the B-cell lymphoma cell
line U698 was used as a negative control.
Westem bloffing
Cells harvested from cultures in exponential growth were boiled in
Laemmli's lysis buffer (Laemmli, 1970) for 5 mnm. Proteins were
separated by 9% sodium dodecyl sulphate polyacrylamide gel
electrophoresis and transferred to a polyvinylidene fluoride
(PVDF) membrane. The mouse monoclonal antibodies PAbl8Ol
(Oncogene Science) and PMG3-245 (Pharmingen) were used for
specific staining ofp53 and pRb. Staining was performed using a
three-layer procedure, using biotinylated anti-mouse antibody
(Amersham Life Science) as second layer, streptavidin-alkalin
phosphatase (Amersham Life Science) as third layer and
BCIP/NBT (Sigma) as substrate.
Statistical analysis
Statistical comparsons of data were performed by parametric
analysis using Student's t-tests and one-way analysis of vanrance.
Multivanrate statistical analysis was applied to compare measured
quantities in the phases of the cell cycle for each of the four cell
lines (Johnsen and Wichern 1992). A significance criterion of
P < 0.05 was used.
RESULTS
The melanoma cells are arrested in all cell cycle phases
during hypoxia treatment
The cell number of the D-12 line remained constant dunrng
hypoxia treatment (Figure 1A). Measurements of the cell cycle
distribution of D-12 cells by flow cytometry revealed no signifi-
cant changes during hypoxia treatment (Figure IB). Similar results
were obtained for the other three lines. The constant cell number
together with the unchanged cell cycle distribution during hypoxia
treatment indicate that the melanoma cells were growth arrested in
all phases ofthe cell cycle immediately after the hypoxic environ-
ment was established.
Hypoxia treatment does not induce apoptosis, alfthough
the energy status of the melanoma cells is slightly
decreased
The survival of D-12 cells decreased with increasing time of
hypoxia treatment (Figure IC), with a mean surviving fraction of
0.45 after 16 h of hypoxia treatment. Quantitatively similar
survival curves were obtained for the other three melanoma lines.
The fraction of cells that were scored apoptotic was less than 2%
after 16 h ofhypoxia treatment. This fraction was not significantly
different from that ofaerobic control cells (P >0.05) for any ofthe
melanoma lines (data not shown). The adenylate energy charge
values (mean ± s.e.) after 16 h of hypoxia treatment were 0.79 ±
0.03 (A-07), 0.84 ± 0.03 (D-12), 0.84 ± 0.02 (R-18) and 0.68 +
0.02 (U-25). The control values for aerobic cells were 0.92 ± 0.01
(A-07). 0.94 ± 0.01 (D-12) and 0.91 ± 0.01 (R-18 and U-25). The
adenylate energy charge was significantly lower for the hypoxia-
treated cells than forthe control cells for all cell lines (P < 0.0001).
p53 protein is induced specifically in S-phase under
hypoxic condifions
An example of results from flow cytometric analysis of aerobic
control cells and hypoxia-treated D-12 cells which were stained
for p53 protein and DNA content is shown in Figure 2. The
histograms in Figure 2B and F show the distributions of p53
protein throughout the cell cycle for aerobic control cells and
hypoxia-treated cells respectively. Hypoxic conditions induced
accumulation ofp53 protein in a cell cycle-dependent manner. To
investigate this cell cycle-dependent accumulation of p53 protein
more precisely, histograms ofp53 protein content were generated
for each phase ofthe cell cycle using narrow gates set in the DNA
histograms (Figure 2C and G). Figure 21-K shows histograms of
p53 protein content in hypoxia-treated cells in G, phase, S-phase
and G, phase respectively. Median values ofhistograms like these
were used to calculate the relative levels of p53 protein in the
different cell cycle phases.
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Figure 6 Fraction pRb- nuclei in aerobic cells @Oi and hypoxia-treated cells through the cell cycle for the cell lines iAi A-07. iBi D-12. (Ci R-18 and (Di
U-25. Five independent expenments with aerobic cells and cells treated with hypoxia for 16 h were carned out
Measurements of relatixe lexve1 of p5 3 protein in each phase of
the cell cxcle under aerobic and hx-poxic condition, are shovx-n in
Ficure 3. The relatix e lexel of p53 protein tended to increase in all
cell c\cle phases after h\poxia treatment. Hoxvever. the hxpoxia-
induced accumulation of p53 protein in S-phase xxas the domi-
natine effect. and a _icnificant increase in p5 protein xwas seen in
all cell lines A-O-. D-l1. R-18. P < 0.0(X)5: t-25. P = 0.01I.
Moreover. the increase in p53 protein in S-phase xvas significantl\
higher than in G pha;se in all cell lines iP < 0.05 and sigoniticantlv
higher than in G phas>e in all cell lines iP < GS0i5) except in R- IS
iP = 0.054i. The total cell populations Figure 2D and H) alSo
,hoxved increa;se, in p53 protein under hxpoxic conditions that
xvere ,iLnficant for all the cell lines (A-(0). P = 0.01: D-12.
P = 0.(X)09: R- 18. P =O.3: U-5. P = 0i.O
\\estern blotting of xxhole cell l\-ates' shox%ed p53 induction
atter hxpoxia treatment. in a;reement xxvith the floxx cvtometrx
result Fig-ure 4).
The retinoblastoma protein is hypophosphorylated and
bound in the nucleus in all phases of the cell cycle
under hypoxic conditions
Fig,ure sho'-> an example of results from tlo" cxtometric
anal-SiS of aerobic A-Fi and hxpoxia-treated G-Li D-12 cell-,
v.hich xvere stained for retinoblastoma protein and DNA content.
Under aerobic conditions. all the cell lines sho%ved pRb- nuclei in
the G phase Figure 5A Figure 5G illustrateS that hxpoxia treat-
ment induced pRb bound in the nucleu!N in all phaseS of the cell
cxcle. Similar histograms xwere obtained for the other cell line.
Histooram's of pRb content in each phase of the cell cxcle xere
g-enerated bx the same method as for p_5.
Measured fractions of pRb- nuclei in the phases of the cell cyxcle
for untreated and hx poxia-treated cells are Show-n in Figure 6. The
fraction of pRb- nuclei in the G phase of aerobic cells did not
differ Sicnificantlv betxveen the four cell lines. The cell lines had a
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Figure 7 Western blot showing the expresson of pRb in A
and U-25 cells from aerobic control cells (C) and hypoxia-tre
Proteins from 5 x 105 cells were baded in each lane. The ba
was due to non-specific binding, as shown in blots stained s
antibody
fraction of (0.18 + 0.05) pRb- nuclei in the G1 ph
cycle under aerobic conditions. The increase in fr
nuclei after hypoxia treatment was statistical
(P<0.05) in any phase of the cell cycle in all
hypoxia-treated cells. the fraction of pRb+ nucle
significantly throughout the cell cycle. The total c
were. therefore. used when comparing the cell line
of the fractions of pRb+ nuclei ofhypoxia-treated c
no statistically significant differences between
(P > 0.05). The fraction of the nuclei that wer
hypoxic conditions was 0.60 ± 0.10.
Westem blotting of whole cell lysates showed a
hypophosphorylated pRb after hypoxia treatmei
consistent with the observation ofpRb binding to ti
hypoxia seen in the flow cytometry experiments.
BrdUrd analysis does not reveal substantia
induced cell cycle phase-specific cell inacti
Some studies have shown that cells in S-phase
hypoxia treatment are most sensitive to the let
hypoxia (Spiro et al. 1984; Amellem and Pettersen
basis ofthe present observations ofS-phase-specifi(
by hypoxia. experiments were performed to inves
hypoxia treatment induced phase-specific cell in;
particularly whether cells in S-phase were mor
hypoxia treatment than cells in other phases. Cell
with BrdUrd for 30 min before hypoxia treatmeni
cell cycle distribution after reoxygenation. Cells t
sizing DNA (S-phase cells) during the labelling pei
porate BrdUrd and show a high FITC fluorescence
cells that are not synthesizing DNA (GI and GjX
The hypoxia-treated cells were reoxygenated and f
time points after reoxygenation. Cells that are reow
hypoxia treatment will re-enter the cell cycle be
metabolically viable immediately after hypoxia tre
and Sutherland. 1989). However. a certain number
clonogenically dead. and will at some time point al
tion stop cycling and disintegrate. These dead cells
to the surface of the glass dishes. and will. therefor
ofthe fixed cell population. Thus. analysis ofBrdU
content over a broad time period afterreoxygenatioi
whether the majority of the inactivated cells we
durinc hypoxia.
An example of results from flovw cytometric anal
control cells and hypoxia-treated A-07 cells stain
and DNA content is shown in Figure 8. The
BrdUrd-negative (Rl) and BrdUrd-positive (R2) z
cells through the cell cycle immediately after BrdUrd incorpora-
tion is shown in Figure 8A. The cell cycle distribution of BrdUrd-
negative (RI) and BrdUrd-positive (R2) hypoxia-treated cells is
shown at Oh (B). 4 h (C) and 13 h (D) after hypoxia treatment. As
pRbj<ts expected from Figure lB. there were no significant differences
between the aerobic control cells (Figure 8A) and the hypoxia-
07, D-12, R-18 treated cells (Figure 8B) immediately after BrdUrd incorporation
ratnd Cells (H). or hypoxia treatment. With increasing reoxygenation times (up to mid above pRb
C
vithout the pRb 24 h). the BrdUrd-positive hypoxia-treated cells became gradually
distributed throughout all phases ofthe cell cycle. Four hours after
reoxygenation. BrdUrd-labelled cells (R2) from hypoxia-treated
populations had moved on to GJM and the next G1 (Figure 8C).
iase of the cell although the cell cycle time ofthe hypoxia-treated cells seemed to
-action of pRb+ be increased compared with aerobic control cells (data not shown).
Ily significant Thirteen hours after reoxygenation (Figure 8D). cells that were in
cell lines. For S-phase during hypoxia were distributed among all cell cycle
i did not vary phases. Thus. at least some of the cells which were in S-phase
ell populations during the hypoxia treatment were still cycling. Cells in G and
os. Comparison G/M phase during hypoxia treatment (BrdUrd-negative cells)
ells resulted in were also cycling (Figure 8D). Moreover. the ratio of BrdUrd-
the cell lines negative and BrdUrd-positive hypoxia-treated cells did not varv
re pRb+ under substantially during the first 24 h of reoxygenation. The ratios of
BrdUrd-negative and BrdUrd-positive ceHls at time points later
ccumulation of than 24 h were not analysed. as they were disturbed bv cell divi-
nt (Figure 7). sion. Thus. the BrdUrd analysis did not reveal anv substantial
ie nucleus after hypoxia-induced cell cycle-specific inactivation during the first
24 h ofreoxygenation.
I hypoxia- DISCUSSION
ivatlonl Cells expressing wild-type p53 accumulate p53 protein when
at the start of exposed to stresses such as ionizing radiation. UV light. heat
thal effects of shock. starvation and hypoxia (Ko and Prives. 1996). We found a
. 1991). On the significant hypoxia-induced increase in p53 protein level in the
c p53 induction S-phase of four melanoma cell lines that are wild type for p53.
stigate whether Moreover, the increase in p53 level in S-phase was significantly
activation. and higher than in GI phase in all cell lines. and significantly higher
re sensitive to than in G, phase in three out of four cell lines. Cell cycle-depen-
s were labelled dent accumulation of p53 by hypoxia treatment has not been
It to follow the reported previously. In a recent study of three human wild-type
hat are synthe- p53 cell lines.y-irradiation was shown to induce p53 selectivelv in
nod will incor- G, phase and early S-phase (Komarova et al. 1997). Moreover. UV
compared with radiation of wild-type p53 NIH3T3 cells induced p53 selectively
~l phase cells). in the S-phase ofcells that were synchronized by serum starsation
fixed at several (Haapajarvi et al. 1995). In contrast. p53 induction by heat shock
tygenated after and UV has been shown to be independent of cell cycle phase in
cause they are human fibroblasts (Yamaizumi and Sugano. 1994: Sugano et al.
matment (Kwok 1995). The p53 induction by hypoxia. however. cannot be
ofthe cells are compared with that of DNA-damaging treatments because
fterreoxygena- hypoxia probably induces little or no DNA damage. Whereas
will not attach DNA lesions in cells may trigger p53 accumulation to maintain
-e. not be a part genomic integrity (Lane. 1992). neither the trigger for hypoxia-
rd versus DNA induced p53 accumulation nor all cellular effects of p53 during
n should reveal hypoxia are known.
ere in S-phase In the present study. p53 induction by hypoxia was only studied
in melanoma cell lines that are wild type forp53. There are rather
lysis of aerobic few reports in which cell lines with mutations in thep53 gene have
led for BrdUrd been exposed to hypoxia. Graeberet al (1994) reported no increase
distribution of in nuclear p53 protein levels of human prostate cell lines DU-145
aerobic control and PC-3. which contain only mutant p53. after exposure to
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Figure 8 Flow cytometric analysis of A-07 cells stained for BrdUrd and DNA content. The cells were labelled with BrdUrd for 30 min before hypoxia treatment.
The histograms show DNA content (integrated propidium iodide fluorescence: F31 -A) and BrdUrd content (FITC fluorescence: FL1-H). A represents aerobic
control cells, whereas B-D represent cells exposed to hypoxia for 16 h. Cells were fixed at 0 h (A. B). 4 h C). or 13 h (D) after BrdUrd incorporation (aerobic
cells) or hypoxia treatment. In the dual parameter histograms. BrdUrd-negative (Rl) and BrdUrd-positive (R2) cells are gated. The fraction of cells (in per cent)
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hypoxia. Moreover, no induction of p53 protein was observed
when the mutant p53-expressing breast cancer cell line T47-D was
treated with hypoxia (Amellem et al. 1997). These observations
are in agreement with the lack of increase in p53 levels seen in
most cells with mutant p53 when exposed to DNA-damaging
agents (Kastan et al, 1991: O'Connor et al. 1993).
Hypoxia treatment induced accumulation of hypophosphory-
lated pRb in all the melanoma cell lines. However. only a fraction
ofthe cells showed hypophosphorylated pRb bound to the nucleus.
This cell fraction did not seem to differ between the cell cycle
phases. Our observations are consistent with those of Amellem et
al (1996). who found that pRb was hypophosphorylated in only a
certain fraction of the cell populations when the cells were
exposed to less than 4 p.p.m. oxygen. In their work. however. the
fraction of the cells with hypophosphorylated pRb differed
between cell lines, whereas no significant differences could be
detected between the four melanoma lines studied here.
p53 accumulation induced by DNA-damaging agents can
mediate G, phase arrest (Ko and Prives. 1996). G, arrest by
hypoxia. however. seems to be independent of p53 accumulation
(Graeber et al. 1994). The arrest of the melanoma cells in all
phases ofthe cell cycle did not correlate with the cell cycle-depen-
dent induction of p53. The primary function of p53 induction by
hypoxia treatment is. therefore. probably not to arrest the cells.
Consequently. we suggest that factors other than pS3 are essential
for the hypoxia-induced cell cycle arrest of the melanoma cells.
Several physiological growth inhibitory signals as well as DNA-
damaging agents can block pRb phosphorylation and, thereby.
arrest the cells in G, phase (Weinberg, 1995). However. because
only a fraction of the melanoma cells showed pRb hypophospho-
rylation by hypoxia. pRb activation is probably not the only cause
of the hypoxia-induced cell cycle arrest as all cells were arrested.
Thus. pRb hypophosphorylation does not seem to be essential for
the hypoxia-induced cell cycle arrest of the melanoma cells. in
accordance with the observations of Amellem et al (1996).
The arrest of cells in the cycle has been observed in different
cell lines when exposed to a sufficiently low oxygen concentra-
tion. However. although all cell lines are arrested on the GI/S
border by hypoxia. some cell lines progress from mitosis to G,
(Spiro et al. 1984: Amellem and Pettersen. 1991). whereas others
are also arrested in mitosis (Shrieve et al, 1983. the present study).
The differences in cell cycle arrest between cell lines are probably
not caused by different levels of oxygenation. as all investigators
used an oxygen concentration of less than 10 p.p.m. Thus, there
seems to be cell line-specific differences in the regulation of the
hypoxia-induced cell cycle arrest. As most of the cell lines used in
these experiments are tumour lines. such differences could be due
to mutations. causing changes in the expression of so far unknown
proteins regulating the cell cycle progression during hypoxia.
Several studies have suggested a link between p53 and pRb in
the control ofcell growth (Demers et al. 1994: Hickman et al. 1994:
Slebos et al. 1994: Haupt et al. 1995). When cells are exposed to
DNA-damaging agents. the p53 induction leads to an increase in
p21. At high protein concentrations. p21 inhibits the functions of
CDKs (cyclin-dependent kinases). allowing the accumulation of
hypophosphorylated pRb. which might result in radiation-induced
GI arrest. Hypoxia. however. has not been shown to activate thisG,
block pathway. The present data do not support a link between p53
and pRb during hypoxia because p53 was induced in a cell cycle-
specific manner. whereas no cell cycle-dependent differences in the
fraction of cells with hypophosphorylated pRb were detected. Our
observations are consistent with those of Graeber and co-workers
(Graeber et al. 1994). who suggested that hypoxia induces p53
protein by a different pathway to DNA damaging agents.
Moreover. hypoxia-induced hypophosphorylation of pRb is prob-
ably not dependent on functionalp53 (Amellem et al. 1996).
Hypoxic conditions of 10 p.p.m. oxygen for some hours
inevitably led to cell inactivation. despite the ability of cells to
adapt to an oxygen-poor atmosphere. In the melanoma lines.
approximately one-half ofthe cells lost clonogenicity after 16 h of
hypoxia treatment. This cell inactivation is probably not due to
energy depletion. as adenylate energy charge values after 16 h of
hypoxia treatment were rather high [between 0.68 ± 0.02 (U-25)
and 0.84 ± 0.03 (D-12 and R- 18)]. Because the adenylate energy
charge of most normal cells are in the range 0.80-0.95 (Stryer.
1988). it is unlikely that the hypoxia-induced decrease in energy
charge will lead to substantial cell inactivation. Results from
studies ofrodent cell lines support the present observation. as they
suggest that other mechanisms were involved in the hypoxia-
induced cell inactivation (Shrieve et al. 1983: Rotin et al. 1986).
However, the mechanism by which hypoxia induces cell inactiva-
tion has not been fully elucidated. In the present work. we
attempted to clarify the roles of p53 and pRb in hypoxia-indtuced
cell inactivation.
Induction of apoptosis has been shown to contribute to hypoxia-
induced cell death (Muschel et al. 1995: Yao et al. 1995: Graeber
et al. 1996: Rofstad et al. 1996b: Shimizu et al. 1996).
Furthermore. a relationship between the accumulation of p53
during hypoxia and hypoxia-induced apoptosis has been suggested
(Graeber et al. 1996). as a parallel to the p53-dependent apoptotic
pathway induced by DNA damage. The hypoxia-induced p53
accumulation in S-phase melanoma cells did not induce apoptosis.
Whereas all the melanoma lines showed a significant increase in
p53 level after 16 h of hypoxia treatment. none of the melanoma
lines showed a significant increase in the apoptotic fraction. The
lack of apoptosis induction despite the significant pS3 accumula-
tion in the melanoma lines suggests that induction of p53 by
hypoxia does not necessarily lead to apoptosis in tumour cells that
are wild type for p53. A possible overexpression of the proteins
Bcl-2 and Bcl-xL might explain the lack of hypoxia-induced apop-
tosis in the melanoma cell lines, as these proteins have been shown
to prevent hypoxia-induced apoptosis (Graeber et al. 1996:
Shimizu etal. 1996).
Some studies have shown. by measuring clonogenic survival.
that cells in S-phase at the start of hypoxia treatment are most
sensitive to the lethal effects of hypoxia (Spiro et al. 1984:
Amellem and Pettersen. 1991). However, others have found little
difference in the survival of cells to hypoxia during the cell cycle
(Kwok and Sutherland. 1989). The BrdUrd analysis of melanoma
cells did not reveal any substantial cell cycle phase-specific inacti-
vation during the first 24 h after hypoxia treatment. However. as
the applied method is rather approximate. we cannot exclude the
possibility that a larger fraction of S-phase cells than of G, and
G./M cells are inactivated after hypoxia treatment. Nevertheless.
our results suggest that many cells residing in S-phase during
hypoxia treatment survive. in contrast to a previous study on
human cells (Amellem and Pettersen. 1991).
In conclusion, four human melanoma cell lines exposed to
hypoxia showed accumulation ofp53 pnrmarily in the S-phase and
induction of hypophosphorylated pRb in all phases of the cell
cycle. The hypoxia-induced p53 accumulation was not associated
with apoptosis or cell cycle-specific cell inactivation. Moreover.
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neither p53 accumulation norpRb hypophosphorylation seemed to
be essential for the hypoxia-induced cell cycle block seen in all
phases ofthe cell cycle.
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